文献速递其他结缔组织病

商业肌炎特异性自身抗体检测对照免疫沉淀法的分析性能:系统综述与荟萃分析

Analytical performance of commercial myositis-specific autoantibody tests evaluated against immunoprecipitation assays as a reference standard: A systematic review and meta-analysis.
PubMed 文献 · Semin Arthritis Rheum · 2025-10-27

该系统综述与荟萃分析共纳入23项研究,以免疫沉淀法为参考标准,评估商业肌炎特异性自身抗体(MSA)检测的分析性能。LBA与EIA是评估最多的方法;各MSA检测合并特异度为94.7%–99.3%,合并敏感度因抗体与方法而异,LBA的假阳性是常见问题(抗EJ除外),假阳性与假阴性仍是商业MSA检测的主要挑战。

要点

  • 以免疫沉淀法为参考标准,23项研究均判为QUADAS-2各域低偏倚风险。
  • 合并敏感度最高为EIA检测抗MDA5(95.7%),LBA检测抗Mi-2、抗NXP2、抗TIF1-γ敏感度较低。
  • 各MSA检测合并特异度为94.7%–99.3%,LBA假阳性常见,但抗EJ除外。

核心结论

  • 假阳性与假阴性结果仍是商业MSA检测应用中的显著挑战。

研究设计与样本

  • 系统检索PubMed、Web of Science与Scopus截至2024年7月的文献,最终23项研究纳入,并以QUADAS-2评估研究质量。

主要发现

  • LBA为最常评估的商业检测(16项研究),其次为EIA(9项研究)。
  • 合并敏感度最高为EIA检测抗MDA5(95.7%),其次为LBA检测抗SAE(88.3%)、抗PL-12(87.2%)、抗Jo-1与抗MDA5(均为82.8%)。
  • LBA检测抗Mi-2(67.4%)、抗NXP2(69.7%)、抗TIF1-γ(63.8%)的合并敏感度较低。
  • 各MSA检测合并特异度为94.7%–99.3%;LBA假阳性为常见问题,但抗EJ除外。

关键数值与推荐

  • 23项纳入研究在QUADAS-2所有域均判为低偏倚风险。
  • 合并敏感度:EIA抗MDA5 95.7%;LBA抗SAE 88.3%、抗PL-12 87.2%、抗Jo-1 82.8%、抗MDA5 82.8%、抗Mi-2 67.4%、抗NXP2 69.7%、抗TIF1-γ 63.8%。
  • 合并特异度范围为94.7%–99.3%。

临床怎么用

  • 原文未报告临床应用建议。

局限性

  • 原文未述局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the analytical performance of commercial myositis-specific autoantibody (MSA) assays against immunoprecipitation (IP) assays. METHODS: A systematic literature search was conducted in PubMed, Web of Science, and Scopus through July 2024. Data were extracted on study design, participant characteristics, index tests, and 2 × 2 contingency tables for diagnostic performance. Study quality was assessed using the QUADAS-2 tool. Sensitivity and specificity were calculated for each dataset and presented as paired forest plots and summary receiver operating characteristic (SROC) curves. A hierarchical SROC model was used to estimate pooled sensitivity and specificity for meta-analysis. RESULTS: Of 3156 articles, 23 met inclusion criteria and were judged to have low risk of bias across all QUADAS-2 domains. The most frequently evaluated commercial assay was the line blot assay (LBA; 16 studies), followed by enzyme immunoassay (EIA; 9 studies). In the meta-analyses, the highest pooled sensitivity was observed for anti-MDA5 with EIA (95.7 %), followed by anti-SAE with LBA (88.3 %), anti-PL-12 with LBA (87.2 %), and anti-Jo-1 and anti-MDA5 with LBA (82.8 %). Lower sensitivities were observed for anti-Mi-2 (67.4 %), anti-NXP2 (69.7 %), and anti-TIF1-γ (63.8 %) with LBA. Pooled specificity ranged from 94.7 % to 99.3 % across MSA assays, but a false-positive result was a common concern for LBA, except for anti-EJ. CONCLUSION: False-positive and false-negative results remain a significant challenge in the use of commercial MSA assays.

来源:Semin Arthritis Rheum,查看原文。版权归原作者所有。

引用

  1. Gono T, Gil-Vila A, Selva-O'Callaghan A, et al. Analytical performance of commercial myositis-specific autoantibody tests evaluated against immunoprecipitation assays as a reference standard: A systematic review and meta-analysis. Semin Arthritis Rheum. 2025. PMID: 41176843. doi:10.1016/j.semarthrit.2025.152858

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。